Enefexine

Enefexine
Clinical data
Other names	4-(4-Ethylphenyl)piperidine
Identifiers
	IUPAC name 4-(4-ethylphenyl)piperidine;
CAS Number	67765-04-2 ; 67765-33-7 (hydrochloride);
PubChem CID	208916;
ChemSpider	181012;
UNII	2JMM46GA2V;
ChEMBL	ChEMBL2106188;
CompTox Dashboard (EPA)	DTXSID8057803 ;
Chemical and physical data
Formula	C13H19N
Molar mass	189.302 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCC1=CC=C(C=C1)C2CCNCC2;
	InChI InChI=1S/C13H19N/c1-2-11-3-5-12(6-4-11)13-7-9-14-10-8-13/h3-6,13-14H,2,7-10H2,1H3; Key:NDPOGPAZKKPOPV-UHFFFAOYSA-N;

Enefexine (INNTooltip International Nonproprietary Name), also known as 4-(4-ethylphenyl)piperidine, is a drug of the phenylpiperidine group which is described as an antidepressant but was never marketed.^[1]^[2] It was first described in the literature by 1983.^[1]^[3] The drug was developed by Ciba-Geigy.^[3]

References

^ ^a ^b Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 519. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
^ https://iris.who.int/bitstream/handle/10665/379226/9789240099388-eng.pdf
^ ^a ^b "Process for preparing phenylazacycloalkanes". Google Patents. 31 January 1983. Retrieved 20 October 2024.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[Elks2014-1] Elks, J. (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 519. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.

[WHO2024-2] ttps://iris.who.int/bitstream/handle/10665/379226/9789240099388-eng.pdf

[CH634298A5-3] "Process for preparing phenylazacycloalkanes". Google Patents. 31 January 1983. Retrieved 20 October 2024.

[1]

[2]

[3]

Enefexine

See also

References